Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 476

    1.

    High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.

    Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, Suraci C, Capizzi M, Arpi ML, Bazzigaluppi E, Dotta F, Bosi E; Non Insulin Requiring Autoimmune Diabetes Study Group.

    Diabetes Care. 2007 Apr;30(4):932-8.PMID: 17392553 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.

    Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R; NIRAD Study Group.

    Diabetes Care. 2008 Mar;31(3):534-8. Epub 2007 Dec 4.PMID: 18056891 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).

    Takeda H, Kawasaki E, Shimizu I, Konoue E, Fujiyama M, Murao S, Tanaka K, Mori K, Tarumi Y, Seto I, Fujii Y, Kato K, Kondo S, Takada Y, Kitsuki N, Kaino Y, Kida K, Hashimoto N, Yamane Y, Yamawaki T, Onuma H, Nishimiya T, Osawa H, Saito Y, Makino H; Ehime Study.

    Diabetes Care. 2002 Jun;25(6):995-1001.PMID: 12032105 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.

    Lindholm E, Hallengren B, Agardh CD.

    Diabetes Metab Res Rev. 2004 Mar-Apr;20(2):158-64.PMID: 15037992 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.

    Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, Yoshioka K, Kitagawa Y, Nakano K, Yoshikawa T, Nakamura N.

    Immunol Lett. 2005 Jul 15;99(2):180-5. Epub 2005 Mar 17.PMID: 16009268 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes.

    Genovese S, Bazzigaluppi E, Gonçalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM, Bardini G, Vaccaro O, Riccardi G, Travaglini P, Morenghi E, Bosi E, Pozzilli P.

    Eur J Endocrinol. 2006 Mar;154(3):441-7.PMID: 16498058 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [Identification of the two subtypes of latent autoimmune diabetes in adults by glutamic acid decarboxylase 65 antibody titers]

    Li X, Zhou ZG, Huang G, Yan X, Yang L, Hu BY.

    Zhonghua Nei Ke Za Zhi. 2003 Jan;42(1):7-10. Chinese. PMID: 12757655 [PubMed - indexed for MEDLINE]Related articles

    8.

    Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.

    Tiberti C, Giordano C, Locatelli M, Bosi E, Bottazzo GF, Buzzetti R, Cucinotta D, Galluzzo A, Falorni A, Dotta F.

    Diabetes. 2008 May;57(5):1276-83. Epub 2008 Mar 10.PMID: 18332100 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.

    Li X, Yang L, Zhou Z, Huang G, Yan X.

    Chin Med J (Engl). 2003 Nov;116(11):1728-32.PMID: 14642146 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.

    Biesenbach G, Auinger M, Clodi M, Prischl F, Kramar R; Diabetic Nephropathy Study Group of the Austrian Society of Nephrology.

    Nephrol Dial Transplant. 2005 Mar;20(3):559-65. Epub 2005 Jan 25.PMID: 15671073 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?]

    Calsolari MR, Rosário PW, Reis JS, Silva SC, Purisch S.

    Arq Bras Endocrinol Metabol. 2008 Mar;52(2):315-21. Review. Portuguese. PMID: 18438542 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.

    Decochez K, Tits J, Coolens JL, Van Gaal L, Krzentowski G, Winnock F, Anckaert E, Weets I, Pipeleers DG, Gorus FK.

    Diabetes Care. 2000 Jun;23(6):838-44.PMID: 10841006 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.

    Törn C, Landin-Olsson M, Ostman J, Scherstén B, Arnqvist H, Blohmé G, Björk E, Bolinder J, Eriksson J, Littorin B, Nyström L, Sundkvist G, Lernmark A.

    Diabetes Metab Res Rev. 2000 Nov-Dec;16(6):442-47.PMID: 11114103 [PubMed - indexed for MEDLINE]Related articles

    14.

    High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.

    Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, Saruta T.

    J Autoimmun. 1999 Mar;12(2):131-5.PMID: 10047433 [PubMed - indexed for MEDLINE]Related articles

    16.

    Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus.

    Bárová H, Perusicová J, Hill M, Sterzl I, Vondra K, Masek Z.

    Physiol Res. 2004;53(3):279-86.PMID: 15209535 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.

    Korhonen S, Knip MM, Kulmala P, Savola K, Akerblom HK, Knip M; Finnish Study Group for ICA Screening.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):43-8.PMID: 11921417 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.

    Katulanda P, Shine B, Katulanda GW, Silva A, Asfir EL, Sheriff R, Somasundaram N, Long AE, Bingley PJ, McCarthy MI, Clark A, Matthews DR.

    Diabetologia. 2008 Aug;51(8):1368-74. Epub 2008 Jun 5.PMID: 18528678 [PubMed - indexed for MEDLINE]Related articles

    19.

    Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.

    Damanhouri LH, Dromey JA, Christie MR, Nasrat HA, Ardawi MS, Robins RA, Todd I.

    Diabet Med. 2005 Apr;22(4):448-52.PMID: 15787671 [PubMed - indexed for MEDLINE]Related articles

    20.

    Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry.

    De Block CE, De Leeuw IH, Rooman RP, Winnock F, Du Caju MV, Van Gaal LF.

    Diabet Med. 2000 Aug;17(8):618-22.PMID: 11073185 [PubMed - indexed for MEDLINE]Related articles